Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: Hum Mol Genet. 2006 Dec 7;16(1):24–35. doi: 10.1093/hmg/ddl441

Table 1.

SNPs with primary model p-value < 0.0001. Listed genes are within 10kb of the SNP position

SNP Gene Chr Pos(bp) Risk Allele h Primary p-value Male odds ratio (95%CI) Female odds ratio (95% CI)
rs2836823 21 39,302,119 T (0.48/0.4) 1.53E-06 1.35 (1.08-1.68) 1.46 (1.23-1.73)
rs4142041 CTNNA3 10a 68,310,957 G (0.41/0.34) 5.64E-06 1.73 (1.37-2.2)* 1.14 (0.97-1.35)*
rs999i GPSM3, AGPAT1, NOTCH4, RNF5, AGER, PBX2, AGER 6 32,261,864 C (0.96/0.94) 1.42E-05 1.92 (1.06-3.45) 2.53 (1.62-3.95)
rs12623467 NRXN1 2g 51,136,740 C (0.96/0.92) 1.48E-05 2.42 (1.51-3.88) 1.57 (1.14-2.16)
rs1782159 14b 40,826,319 C (0.25/0.2) 1.87E-05 1.97 (1.46-2.65)* 1.09 (0.87-1.36)*
rs12380218 VPS13A 9c 77,165,214 G (0.24/0.19) 2.09E-05 1.18 (0.9-1.55) 1.56 (1.28-1.91)
rs2022443 VPS13A 9c 77,099,406 G (0.24/0.19) 2.49E-05 1.12 (0.86-1.45)* 1.57 (1.29-1.91)*
rs2673931 TRPC7 5d 135,717,335 T (0.66/0.61) 3.89E-05 1.68 (1.34-2.12)* 1.04 (0.87-1.24)*
rs4142603 9c 76,998,948 C (0.25/0.19) 4.05E-05 1.15 (0.9-1.47) 1.52 (1.26-1.84)
rs1031006 5 14,040,103 A (0.67/0.62) 4.30E-05 0.98 (0.78-1.24)* 1.49 (1.25-1.78)*
rs2791480 CLCA1 1 86,680,605 G (0.78/0.72) 4.38E-05 1.53 (1.19-1.97) 1.33 (1.1-1.61)
rs10049135 3 72,731,670 A (0.89/0.86) 4.65E-05 2.09 (1.51-2.91)* 0.96 (0.75-1.24)*
rs11145381 VPS13A 9c 77,144,695 C (0.23/0.18) 4.72E-05 1.19 (0.91-1.57) 1.54 (1.26-1.88)
rs2798983 14b 40,841,983 C (0.28/0.22) 4.77E-05 1.63 (1.25-2.13) 1.28 (1.05-1.55)
rs2546657 TRPC7 5d 135,711,634 A (0.66/0.62) 4.96E-05 1.67 (1.33-2.09)* 1.01 (0.85-1.2)*
rs1782182 14b 40,766,891 G (0.31/0.25) 5.28E-05 1.72 (1.33-2.22)* 1.14 (0.95-1.38)*
rs10490162 NRXN1 2 51,159,308 T (0.91/0.86) 5.66E-05 1.92 (1.34-2.75) 1.39 (1.08-1.79)
rs11694463 2 12,732,219 C (0.12/0.09) 6.10E-05 2.1 (1.4-3.15) 1.37 (1.05-1.78)
rs17706334 11e 108,486,074 A (0.97/0.94) 6.38E-05 1.71 (1.05-2.8) 2.19 (1.44-3.33)
rs17706299 11e 108,486,027 C (0.97/0.94) 6.51E-05 1.71 (1.05-2.79) 2.19 (1.44-3.33)
rs13277254 CHRNB3 8f 42,669,139 A (0.81/0.76) 6.54E-05 1.19 (0.92-1.55) 1.55 (1.26-1.91)
rs12467557 NRXN1 2g 51,153,921 A (0.96/0.93) 6.88E-05 2.53 (1.48-4.31) 1.62 (1.14-2.3)
rs17633258 11e 108,491,084 C (0.97/0.94) 7.31E-05 1.9 (1.14-3.15) 2.11 (1.38-3.23)
rs4859365 4 35,345,098 G (0.52/0.45) 7.72E-05 1.49 (1.2-1.86) 1.24 (1.04-1.47)
rs10793832 FBXL17 5 107,348,129 C (0.32/0.26) 8.13E-05 1.11 (0.87-1.41) 1.47 (1.23-1.76)
rs1782134 14b 40,785,318 T (0.3/0.25) 8.18E-05 1.68 (1.3-2.18)* 1.15 (0.96-1.39)*
rs11157219 14b 40,852,451 G (0.3/0.24) 8.78E-05 1.7 (1.31-2.2)* 1.16 (0.96-1.4)*
rs2302673 FTO 16 52,625,622 T (0.87/0.84) 8.85E-05 1.04 (0.76-1.44)* 1.69 (1.33-2.16)*
rs1612945 14b 40,805,691 C (0.3/0.24) 8.91E-05 1.66 (1.29-2.15)* 1.18 (0.98-1.42)*
rs1782145 14b 40,800,126 C (0.3/0.24) 9.06E-05 1.65 (1.28-2.14)* 1.18 (0.98-1.42)*
rs1782141 14b 40,795,921 A (0.3/0.25) 9.20E-05 1.68 (1.3-2.16)* 1.15 (0.96-1.39)*
rs17633211 11e 108,490,715 T (0.97/0.94) 9.33E-05 1.9 (1.14-3.15) 2.09 (1.37-3.19)
rs6474413 CHRNB3 8f 42,670,221 T (0.81/0.76) 9.36E-05 1.18 (0.91-1.53) 1.54 (1.25-1.9)
rs9332406 CTNNA3 10a 68,340,205 A (0.4/0.34) 9.71E-05 1.63 (1.28-2.06)* 1.11 (0.94-1.32)*
rs1782144 14b 40,799,523 G (0.3/0.24) 9.88E-05 1.65 (1.28-2.14)* 1.18 (0.98-1.43)*
*

Significantly different Odds Ratio for men and women.

a

Two Chr 10 SNPs with r2 correlation of 0.89

b

Nine Chr 14 SNPs with minimum pair-wise r2 correlation of >0.85

c

Four Chr 9 SNPs with minimum pair-wise r2 correlation of >0.85

d

Two Chr 5 SNPs with r2 correlation of 0.99 (the other two Chr 5 SNPs are uncorrelated)

e

Four Chr 11 SNPs with minimum pair-wise r2 correlation of >0.95

f

Two Chr 8 SNPs with r2 correlation of 1

g

Two Chr 2 SNPs with r2 correlation of 0.91 (the other two Chr 2 SNPs have pair-wise correlations of <50%).

h

The risk allele is chosen arbitrarily to be the allele more prevalent in cases to facilitate comparison of effect sizes across SNPs. This does not imply that the effect of the variant is known in any case; the other allele could be protective. In addition, the alleles could be complementary to those reported in dbSNP (see online SNP information).

i

The allele frequency for rs999 is quite different in these data than reported in dbSNP; this may represent a failure to accurately genotype this SNP in this study.